Tianyikang Biotechnology
About Tianyikang Biotechnology
Tianyikang Biotechnology focuses on medical research and the development and application of next-generation cell immunotherapy products.
Company Facts
- Operating status: Active
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Feb 2026)
Canonical: https://fsome.com/organization/tianyikang-biotechnology-12414093 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.